Chapter/Section Purchase

1 Celecoxib Market Overview
1.1 Product Overview and Scope of Celecoxib
1.2 Celecoxib Segment by Type
1.2.1 Global Celecoxib Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 50mg
1.2.3 100mg
1.2.4 200mg
1.2.5 400mg
1.3 Celecoxib Segment by Application
1.3.1 Global Celecoxib Sales Comparison by Application: (2021-2027)
1.3.2 Rheumatoid arthritis
1.3.3 osteoarthritis
1.3.4 Acute pain
1.3.5 Musculoskeletal pain
1.3.6 Other diseases
1.4 Global Celecoxib Market Size Estimates and Forecasts
1.4.1 Global Celecoxib Revenue 2016-2027
1.4.2 Global Celecoxib Sales 2016-2027
1.4.3 Celecoxib Market Size by Region: 2016 Versus 2021 Versus 2027

2 Celecoxib Market Competition by Manufacturers
2.1 Global Celecoxib Sales Market Share by Manufacturers (2016-2021)
2.2 Global Celecoxib Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Celecoxib Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Celecoxib Manufacturing Sites, Area Served, Product Type
2.5 Celecoxib Market Competitive Situation and Trends
2.5.1 Celecoxib Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Celecoxib Players Market Share by Revenue
2.5.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Celecoxib Retrospective Market Scenario by Region
3.1 Global Celecoxib Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Celecoxib Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Celecoxib Market Facts & Figures by Country
3.3.1 North America Celecoxib Sales by Country
3.3.2 North America Celecoxib Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Celecoxib Market Facts & Figures by Country
3.4.1 Europe Celecoxib Sales by Country
3.4.2 Europe Celecoxib Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Celecoxib Market Facts & Figures by Region
3.5.1 Asia Pacific Celecoxib Sales by Region
3.5.2 Asia Pacific Celecoxib Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Celecoxib Market Facts & Figures by Country
3.6.1 Latin America Celecoxib Sales by Country
3.6.2 Latin America Celecoxib Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Celecoxib Market Facts & Figures by Country
3.7.1 Middle East and Africa Celecoxib Sales by Country
3.7.2 Middle East and Africa Celecoxib Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Celecoxib Historic Market Analysis by Type
4.1 Global Celecoxib Sales Market Share by Type (2016-2021)
4.2 Global Celecoxib Revenue Market Share by Type (2016-2021)
4.3 Global Celecoxib Price by Type (2016-2021)

5 Global Celecoxib Historic Market Analysis by Application
5.1 Global Celecoxib Sales Market Share by Application (2016-2021)
5.2 Global Celecoxib Revenue Market Share by Application (2016-2021)
5.3 Global Celecoxib Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Pfizer Inc
6.1.1 Pfizer Inc Corporation Information
6.1.2 Pfizer Inc Description and Business Overview
6.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc Celecoxib Product Portfolio
6.1.5 Pfizer Inc Recent Developments/Updates
6.2 Teva
6.2.1 Teva Corporation Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Teva Celecoxib Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Corporation Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Mylan Celecoxib Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Apotex Celecoxib Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Lupin
6.5.1 Lupin Corporation Information
6.5.2 Lupin Description and Business Overview
6.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lupin Celecoxib Product Portfolio
6.5.5 Lupin Recent Developments/Updates
6.6 Hengrui Medicine
6.6.1 Hengrui Medicine Corporation Information
6.6.2 Hengrui Medicine Description and Business Overview
6.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Hengrui Medicine Celecoxib Product Portfolio
6.6.5 Hengrui Medicine Recent Developments/Updates

7 Celecoxib Manufacturing Cost Analysis
7.1 Celecoxib Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Celecoxib
7.4 Celecoxib Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Celecoxib Distributors List
8.3 Celecoxib Customers

9 Celecoxib Market Dynamics
9.1 Celecoxib Industry Trends
9.2 Celecoxib Growth Drivers
9.3 Celecoxib Market Challenges
9.4 Celecoxib Market Restraints

10 Global Market Forecast
10.1 Celecoxib Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Celecoxib by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Celecoxib by Type (2022-2027)
10.2 Celecoxib Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Celecoxib by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Celecoxib by Application (2022-2027)
10.3 Celecoxib Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Celecoxib by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Celecoxib by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer